| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kazunari Ishii, Tomonori Kanda, Takafumi Uemura, Naokazu Miyamoto, Toshiki Yoshikawa, Kenichi Shimada, Shingo Ohkawa, Satoshi Minoshim. Computer-assisted diagnostic system for neurodegenerative dementia using brain SPECT and 3D-SSP. European journal of nuclear medicine and molecular imaging. vol 36. issue 5. 2009-08-11. PMID:19148640. |
to develop a computer-assisted automated diagnostic system to distinguish among alzheimer disease (ad), dementia with lewy bodies (dlb), and other degenerative disorders in patients with mild dementia. |
2009-08-11 |
2023-08-12 |
Not clear |
| E E Benarroch, A M Schmeichel, B N Dugger, P Sandroni, J E Parisi, P A Lo. Dopamine cell loss in the periaqueductal gray in multiple system atrophy and Lewy body dementia. Neurology. vol 73. issue 2. 2009-08-07. PMID:19597132. |
excessive daytime sleepiness (eds) is a common manifestation of multiple system atrophy (msa) and dementia with lewy bodies (dlb) but involvement of these neurons has not yet been explored. |
2009-08-07 |
2023-08-12 |
Not clear |
| Sophie Molloy, Thais Minett, John T O'Brien, Ian G McKeith, David J Bur. Levodopa use and sleep in patients with dementia with Lewy bodies. Movement disorders : official journal of the Movement Disorder Society. vol 24. issue 4. 2009-07-28. PMID:19191343. |
sleep disturbance and excessive daytime somnolence (eds) are features of parkinson's disease (pd) and dementia with lewy bodies (dlb) that may be influenced by dopamine replacement therapy. |
2009-07-28 |
2023-08-12 |
Not clear |
| Roger Lane, Yunsheng He, Christopher Morris, James B Leverenz, Murat Emre, Clive Ballar. BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline. Movement disorders : official journal of the Movement Disorder Society. vol 24. issue 3. 2009-07-27. PMID:19006190. |
the primary objective was to evaluate frequencies of these alleles in dementia with lewy bodies (dlb) and parkinson's disease dementia (pdd). |
2009-07-27 |
2023-08-12 |
human |
| Jan Edler, Brit Mollenhauer, Uta Heinemann, Daniela Varges, Carola Werner, Inga Zerr, Walter J Schulz-Schaeffe. Movement disturbances in the differential diagnosis of Creutzfeldt-Jakob disease. Movement disorders : official journal of the Movement Disorder Society. vol 24. issue 3. 2009-07-27. PMID:19053051. |
we investigated the occurrence and characteristics of movement disturbances in 143 patients neuropathologically confirmed with cjd (n = 100), ad (n = 29), dementia with lewy bodies (dlb) (n = 7), or other diagnoses (n = 7). |
2009-07-27 |
2023-08-12 |
Not clear |
| Robert Perneczky, Peter Häussermann, Alexander Drzezga, Henning Boecker, Oliver Granert, Regina Feurer, Hans Förstl, Alexander Kur. Fluoro-deoxy-glucose positron emission tomography correlates of impaired activities of daily living in dementia with Lewy bodies: implications for cognitive reserve. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. vol 17. issue 3. 2009-07-13. PMID:19454846. |
1) to investigate the neural substrate of impaired activities of daily living (adl) in dementia with lewy bodies (dlb) and 2) to explore, in the context of cognitive reserve, if hypometabolism was more pronounced in well-educated patients at the same level of everyday impairment. |
2009-07-13 |
2023-08-12 |
Not clear |
| Christian Praml, Wolfgang Schulz, Andreas Claas, Jan Mollenhauer, Annemarie Poustka, Rolf Ackermann, Manfred Schwab, Kai-Oliver Henric. Genetic variation of Aflatoxin B1 aldehyde reductase genes (AFAR) in human tumour cells. Cancer letters. vol 272. issue 1. 2009-07-07. PMID:18752886. |
furthermore, human afar1 catalyses the rate limiting step in the synthesis of the neuromodulator gamma-hydroxybutyrate (ghb) and was found elevated in neurodegenerative diseases such as alzheimer's and dementia with lewy bodies (dlb). |
2009-07-07 |
2023-08-12 |
human |
| M Pallàs, J G Pizarro, J Gutierrez-Cuesta, N Crespo-Biel, D Alvira, M Tajes, M Yeste-Velasco, J Folch, A M Canudas, F X Sureda, I Ferrer, A Camin. Modulation of SIRT1 expression in different neurodegenerative models and human pathologies. Neuroscience. vol 154. issue 4. 2009-06-29. PMID:18538940. |
finally, we studied human samples of parkinson's disease (pd), dementia with lewy bodies (dlb) and huntington's diseases (hd). |
2009-06-29 |
2023-08-12 |
mouse |
| Katsuyoshi Mizukami, Toshiaki Homma, Kazutaka Aonuma, Toru Kinoshita, Kenji Kosaka, Takashi Asad. Decreased ventilatory response to hypercapnia in dementia with Lewy bodies. Annals of neurology. vol 65. issue 5. 2009-06-26. PMID:19475659. |
a systematic autonomic dysfunction observed among patients with dementia with lewy bodies (dlb) has recently attracted close attention. |
2009-06-26 |
2023-08-12 |
human |
| Shunichiro Shinagawa, Hiroyoshi Adachi, Yasutaka Toyota, Takaaki Mori, Izumi Matsumoto, Ryuji Fukuhara, Manabu Iked. Characteristics of eating and swallowing problems in patients who have dementia with Lewy bodies. International psychogeriatrics. vol 21. issue 3. 2009-06-24. PMID:19257916. |
it has therefore been assumed that eating problems are also common in patients with dementia with lewy bodies (dlb). |
2009-06-24 |
2023-08-12 |
Not clear |
| Maryse Letiembre, Yang Liu, Silke Walter, Wenlin Hao, Tatjana Pfander, Arne Wrede, Walter Schulz-Schaeffer, Klaus Fassbende. Screening of innate immune receptors in neurodegenerative diseases: a similar pattern. Neurobiology of aging. vol 30. issue 5. 2009-06-22. PMID:17905482. |
in alzheimer's disease (ad), parkinson's disease (pd), dementia with lewy bodies (dlb) and amyotrophic lateral sclerosis (als), neuroinflammatory responses are considered to contribute to neuronal injury. |
2009-06-22 |
2023-08-12 |
human |
| Petra E Spies, René J F Melis, Magnus J C Sjögren, Marcel G M Olde Rikkert, Marcel M Verbee. Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders. Journal of Alzheimer's disease : JAD. vol 16. issue 2. 2009-06-17. PMID:19221426. |
alpha-synuclein is the major constituent of lewy bodies found in neurons in dementia with lewy bodies (dlb) and might be of diagnostic value as a biomarker for dlb. |
2009-06-17 |
2023-08-12 |
Not clear |
| Petra E Spies, René J F Melis, Magnus J C Sjögren, Marcel G M Olde Rikkert, Marcel M Verbee. Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders. Journal of Alzheimer's disease : JAD. vol 16. issue 2. 2009-06-17. PMID:19221426. |
we hypothesized that, as a consequence of increased accumulation of alpha-synuclein intraneuronally in dlb, the levels of alpha-synuclein in cerebrospinal fluid (csf) of dlb patients would be lower than in other dementias. |
2009-06-17 |
2023-08-12 |
Not clear |
| Petra E Spies, René J F Melis, Magnus J C Sjögren, Marcel G M Olde Rikkert, Marcel M Verbee. Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders. Journal of Alzheimer's disease : JAD. vol 16. issue 2. 2009-06-17. PMID:19221426. |
our objective was to investigate the csf levels of alpha-synuclein in several dementia disorders compared to control levels and to investigate the diagnostic value of csf alpha-synuclein as a marker to discriminate between dlb and other types of dementia. |
2009-06-17 |
2023-08-12 |
Not clear |
| Petra E Spies, René J F Melis, Magnus J C Sjögren, Marcel G M Olde Rikkert, Marcel M Verbee. Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders. Journal of Alzheimer's disease : JAD. vol 16. issue 2. 2009-06-17. PMID:19221426. |
we did not find any significant differences in csf alpha-synuclein levels between dlb patients and patients with alzheimer's disease, vascular dementia or frontotemporal dementia. |
2009-06-17 |
2023-08-12 |
Not clear |
| Petra E Spies, René J F Melis, Magnus J C Sjögren, Marcel G M Olde Rikkert, Marcel M Verbee. Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders. Journal of Alzheimer's disease : JAD. vol 16. issue 2. 2009-06-17. PMID:19221426. |
we conclude that in clinically diagnosed patients, alpha-synuclein does not appear to be a useful biomarker for the differentiation between dlb and other types of dementia. |
2009-06-17 |
2023-08-12 |
Not clear |
| Kristofer Schultz, Sara Wiehager, Karin Nilsson, Jørgen E Nielsen, Suzanne G Lindquist, Lena E Hjermind, Birgitte B Andersen, Anders Wallin, Christer Nilsson, Asa Petersé. Reduced CSF CART in dementia with Lewy bodies. Neuroscience letters. vol 453. issue 2. 2009-06-12. PMID:19356602. |
dementia with lewy bodies (dlb) is the second most common form of neurodegenerative dementia after alzheimer's disease (ad). |
2009-06-12 |
2023-08-12 |
Not clear |
| Tomoyuki Miyamoto, Masayuki Miyamoto, Masaoki Iwanami, Keisuke Suzuki, Yuichi Inoue, Koichi Hirat. Odor identification test as an indicator of idiopathic REM sleep behavior disorder. Movement disorders : official journal of the Movement Disorder Society. vol 24. issue 2. 2009-06-08. PMID:18972547. |
reduction of olfactory function in idiopathic rapid-eye-movement (rem) sleep behavior disorder (irbd) is of the same magnitude as that found in patients with parkinson's disease (pd) and dementia with lewy bodies (dlb). |
2009-06-08 |
2023-08-12 |
Not clear |
| S S Williams, J Williams, M Combrinck, S Christie, A D Smith, R McShan. Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease. Journal of neurology, neurosurgery, and psychiatry. vol 80. issue 6. 2009-06-01. PMID:19448090. |
it is not known whether, in patients with mild dementia (mmse score over 20), olfactory function is more impaired in alzheimer disease (ad) than dementia with lewy bodies (dlb). |
2009-06-01 |
2023-08-12 |
Not clear |
| Yuri Kudo, Toru Imamura, Atsushi Sato, Naoto End. Risk factors for falls in community-dwelling patients with Alzheimer's disease and dementia with Lewy bodies: walking with visuocognitive impairment may cause a fall. Dementia and geriatric cognitive disorders. vol 27. issue 2. 2009-05-28. PMID:19182481. |
to identify risk factors for falls in community-dwelling patients with alzheimer's disease (ad) and dementia with lewy bodies (dlb). |
2009-05-28 |
2023-08-12 |
Not clear |